Clinical Trials Search | Clareo Health

Showing 1-2 of 2 trials

Breathe-Easy: Hayfever Care for Patients With Seasonal Allergic Rhinitis

NCT06765239

This waitlist-controlled trial aims to evaluate the therapeutic effectiveness of Hayfever Care by assessing disease-specific symptoms over a 4-week period. Additionally, the study examines the tolerability and safety of the solution.

HayfeverAllergy PollenAllergic Rhinitis

Innowage Limited63 participantsStarted Apr 2024

Jaipur, Rajasthan, India

COMPLETEDPHASE2

Study to Assess the Efficacy and Safety of BDP HFA Nasal Aerosol in Patients 12 Years and Older With SAR

NCT00854360

This is a phase 2, randomized, double-blind, placebo-controlled, parallel-group, 2-week, multi-center, dose-range-finding study in male or female patients (12 years and older) with SAR.

Seasonal Allergic RhinitisHayfever

Teva Branded Pharmaceutical Products R&D, Inc.487 participantsStarted Mar 2009

Mission Viejo, California, United States • San Diego, California, United States • San Diego, California, United States +23 more locations

Data from ClinicalTrials.govTerms

Filters

Filters

Breathe-Easy: Hayfever Care for Patients With Seasonal Allergic Rhinitis

Study to Assess the Efficacy and Safety of BDP HFA Nasal Aerosol in Patients 12 Years and Older With SAR

Breathe-Easy: Hayfever Care for Patients With Seasonal Allergic Rhinitis

Study to Assess the Efficacy and Safety of BDP HFA Nasal Aerosol in Patients 12 Years and Older With SAR